Unconfigured Ad
Collapse
Discussion of next-gen sequencing related bioinformatics: resources, algorithms, open source efforts, etc
| Forums | Topics | Posts | Last Post |
|---|
No forums found.
There are no conversations in this channel.
Please log in to your account to view your subscribed posts.
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by laura, 05-09-2011, 04:42 AM
|
35 responses
107,611 views
0 reactions
|
Last Post
by laura
12-05-2013, 02:37 AM
|
||
|
Started by sci_guy, 01-23-2008, 11:19 PM
|
236 responses
684,111 views
1 reaction
|
Last Post
by ECO
12-25-2009, 06:45 PM
|
||
|
Started by BertieWooster, 09-24-2012, 07:51 AM
|
1 response
2,447 views
0 reactions
|
Last Post
by r-waples
09-24-2012, 08:38 AM
|
||
|
Started by DavidPayne, 09-24-2012, 08:27 AM
|
0 responses
2,086 views
0 reactions
|
Last Post
by DavidPayne
09-24-2012, 08:27 AM
|
||
|
Started by lchang1101, 09-23-2012, 07:18 PM
|
2 responses
1,558 views
0 reactions
|
Last Post
by lchang1101
09-24-2012, 07:22 AM
|
||
|
Started by biofreak, 04-13-2012, 10:15 AM
|
4 responses
1,942 views
0 reactions
|
Last Post
by jme
09-24-2012, 01:56 AM
|
||
|
Started by thepandafactor, 09-23-2012, 05:04 PM
|
0 responses
1,102 views
0 reactions
|
Last Post
|
||
|
Started by billstevens, 09-18-2012, 06:04 PM
|
7 responses
2,678 views
0 reactions
|
Last Post
by billstevens
09-23-2012, 03:17 PM
|
||
|
Started by pgfonseca, 09-22-2012, 03:42 PM
|
0 responses
1,264 views
0 reactions
|
Last Post
by pgfonseca
09-22-2012, 03:42 PM
|
||
|
Started by nasepu, 09-21-2012, 01:13 PM
|
1 response
1,408 views
0 reactions
|
Last Post
|
||
|
Started by shuoguo, 09-21-2012, 01:11 PM
|
2 responses
1,753 views
0 reactions
|
Last Post
by shuoguo
09-21-2012, 05:47 PM
|
||
|
Started by MikeT, 09-20-2012, 04:19 AM
|
4 responses
2,087 views
0 reactions
|
Last Post
by TiborNagy
09-21-2012, 01:38 AM
|
No topics found.
-
Page of 0
-
Filter
widgetinstance 229 (Webinars) skipped due to lack of content & hide_module_if_empty option.
Recent Articles
Collapse
-
by SEQadmin2
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...-
Channel: Articles
07-20-2026, 11:48 AM -
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
-
by SEQadmin2
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...-
Channel: Articles
07-08-2026, 05:17 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, Today, 11:41 AM
|
0 responses
9 views
0 reactions
|
Last Post
by SEQadmin2
Today, 11:41 AM
|
||
|
Started by SEQadmin2, 07-20-2026, 11:10 AM
|
0 responses
22 views
0 reactions
|
Last Post
by SEQadmin2
07-20-2026, 11:10 AM
|
||
|
Started by SEQadmin2, 07-13-2026, 10:26 AM
|
0 responses
35 views
0 reactions
|
Last Post
by SEQadmin2
07-13-2026, 10:26 AM
|